VKTX Management is terrible, they either do not think their results for phase 2 will be good or they just don't care about its investors. The timing of this dilution after they fail to get the Phase 2 done on time and delay it a couple months then dilute us down during this waiting time ? why ? They have enough cash to last them another 8 months...doing this now does not look good. The CEO needs to do a better job recruiting patients for trials and stop putting its investors in a bad spot.
News 
Market Data 
Discover 
